Levi & Korsinsky Launches Fraud Investigation on Behalf of Varonis Systems, Inc. (VRNS) Shareholders

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Varonis Systems, Inc. ("Varonis Systems, Inc.") (NASDAQ:VRNS) concerning possible violations of federal securities laws. On October 28, 2025, Varonis reported third quarter fiscal 2025 revenue below estimates on the back of weaker […]

Lost Money on DexCom, Inc. (DXCM)? Join Class Action Before December 26, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form-2?prid=176621&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Securities Fraud Class Action Filed Against KBR, Inc. (KBR) – Levi & Korsinsky Reminds Investors of November 18, 2025

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your KBR, Inc. (NYSE:KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=176648&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Levi & Korsinsky Urges aTyr Pharma, Inc. (ATYR) Shareholders to Act Before Lead Plaintiff Deadline December 8, 2025

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=176649&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Kingston International College and Tmall Campus Form Strategic Partnership to Build an Education Bridge Between Singapore and China

Kingston International College (Singapore) andTmall Campus have formed a strategic partnership that builds a strong bridge between Singapore and China's education ecosystems, creating new opportunities for students for both countries to learn, connect, and grow across borders. https://mma.prnewswire.com/media/2819350/Kingston_International_College_Tmall_Campus_Form_Strategic_Partnership_Build_Education.jpg This collaboration aims to co-develop, market, and deliver innovative academic and professional programsthat combine real-world relevance with

NOVI Health Launches “It Starts with One: Taking Charge This World Diabetes Month” Campaign to Support Awareness and Wellness in Singapore

In recognition of Diabetes Awareness Month, NOVI Health is honoured to launch “It Starts with One: Taking Charge This World Diabetes Month”, a campaign dedicated to raising awareness, promoting healthy living, and supporting the diabetes community in Singapore. As part of the campaign, NOVI Health will host a series of events and educational initiatives aimed

Levi & Korsinsky Urges CarMax, Inc. (KMX) Shareholders to Act Before Lead Plaintiff Deadline January 2, 2026

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your CarMax, Inc. (NYSE:KMX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/carmax-inc-lawsuit-submission-form?prid=176617&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Did You Lose Money on Cytokinetics, Incorporated (CYTK)? Levi & Korsinsky Urges Investors to Act Before November 17, 2025

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=176616&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock

(NASDAQ:VOR), BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) — Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $10.00 per share. The gross proceeds from the

Scroll to Top